Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Morphine (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population (PROSPER)
Conditions: Chronic Nonmalignant Pain; Pain, Intractable; Pain, Chronic Interventions: Device: Flowonix Prometra® II Programmable Infusion System; Drug: Opioids, Neuropathic pain medications, antispasmodics, NSAIDS, etc. Sponsors: Evolve Restorative Center; Flowonix Medical; Celéri Health; Advanced Infusion Solutions Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Cancer | Cancer & Oncology | Chronic Pain | Morphine | Neurology | Pain | Pain Management | Research | Study